Company intelligence / Profile preview
Universal Cells
Seattle, Washington, USAuniversalcells.com ↗
- Ownership
- Private
- Employees
- ~86
- Development stage
- Preclinical
01
Overview
Universal Cells develops engineered allogeneic stem cells with proprietary nuclease-free gene editing technology to create "universal donor" pluripotent stem cells that can be differentiated into various therapeutic cell types while avoiding immune rejection. Their approach focuses on precise HLA engineering using rAAV vectors, aiming for off-the-shelf cell therapy products suitable for any patient without the need for immunosuppression or matching. The company was acquired by Astellas Pharma in February 2018 but continues operations as an active subsidiary focused on advancing its platform toward clinical applications in regenerative medicine and transplantation.
- Therapeutic areas
- Immunology
- Modalities
- Allogeneic pluripotent stem cells (ESCs and iPSCs)Engineered cell therapies
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Parent company Astellas Pharma Inc.; no other major partnerships disclosed.
Beyond the preview
Go deeper on Universal Cells.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Universal Cells.